Gregory J Divis Avadel Pharmaceuticals PLC (AVDL) insider trading activity

AVDL Quotes by TradingView

Gregory J Divis is Chief Executive Officer of AVADEL PHARMACEUTICALS PLC. Currently has a direct ownership of 211,100 shares of AVDL, which is worth approximately $1.67 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 52,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K
32.68% 3M change
32.68% 12M change
Total Value Held $1.67 Million

Gregory J Divis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2025
BUY
Grant, award, or other acquisition
-
52,000 Added 19.76%
211,100 Ordinary Shares
Aug 10 2023
BUY
Open market or private purchase
$132,000 $13.2 p/Share
10,000 Added 5.91%
159,100 ADSs
May 27 2022
BUY
Open market or private purchase
$102,500 $2.05 p/Share
50,000 Added 25.11%
149,100 ADSs

Also insider at

JAGX
Jaguar Health, Inc. Healthcare
Director
GJD

Gregory J Divis

Chief Executive Officer
Dublin 2, L2

Track Institutional and Insider Activities on AVDL

Follow AVADEL PHARMACEUTICALS PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVDL shares.

Notify only if

Insider Trading

Get notified when an Avadel Pharmaceuticals PLC insider buys or sells AVDL shares.

Notify only if

News

Receive news related to AVADEL PHARMACEUTICALS PLC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVDL